Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

PI3K inhibitors are a class of medication used to treat chronic lymphocytic leukemia (CLL) that has returned after previous treatments. Phosphoinositide 3-kinase (PI3K) inhibitors work by blocking a ...

Q4 2024 Earnings Call Transcript March 31, 2025 Celcuity Inc. misses on earnings expectations. Reported EPS is $-0.85 EPS, ...

A new study on the genetic causes of the PTEN Hamartoma Tumour Syndrome (PHTS) has found that inhibitors of the PI3ka pathway, commonly used as anticancer drugs, are also effective against this ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Good afternoon, ladies and gentlemen, and welcome to the Celcuity fourth quarter and full year 2024 financial results webcast conference call. (Operator Instructions) I would now like to turn the ...

The triplet regimen demonstrated a significant overall survival benefit, a first for PI3K inhibitors in this context. Itovebi, approved for some patients with breast cancer, is the first PI3K ...

Copyright held by the owner/author(s).

During development, cells grow, expand, and migrate to generate tissues and organs in a highly controlled manner. Many ...

Some people taking BTK inhibitors have developed skin cancer or other cancers. Doctors recommend protecting your skin while on these medications to lower this risk. PI3K is another protein ...